Navigation Links
Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
Date:7/28/2008

Japan Market To Benefit from Novel Ingredients and Regulatory Expertise

PROVO, Utah, July 28 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced that the company has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.

Nu Skin Enterprises is the first direct selling company to have such an agreement with Toyo Bio-Pharma. The companies' collaborative development efforts will focus on sharing scientific and regulatory insights, as well as developing proprietary nutraceutical and cosmeceutical products for Nu Skin sales through its worldwide distribution network.

"We expect this relationship with Nu Skin Enterprises to nicely complement our current expertise in natural health supplements," said Yoshi Shiraishi, president and chief operating officer of Toyo Bio-Pharma. "We highly respect the industry-leading research and development capabilities of Nu Skin Enterprises. We believe there is a synergy between the two research teams that both companies can benefit from."

"Toyo Bio-Pharma is a subsidiary of Toyo Shinyaku, which is one of the most reputable supplement and skin care manufacturers in Japan, and we look forward to developing a robust relationship with joint development opportunities," said Joseph Chang, Ph. D., chief scientific officer and executive vice president of product development at Nu Skin Enterprises. "We are eager to leverage their knowledge of navigating regulatory requirements for skin care and supplements in Japan."

About Toyo Bio-Pharma

Toyo Bio-Pharma(TM) (http://www.toyobiopharma.com) is a subsidiary of Toyo Shinyaku Co., Ltd., a research-driven manufacturer committed to providing consumers and clients with high-value ingredients derived from nature. With the most advanced instrumentation, continuous research and commitment to quality and integrity, Toyo Shinyaku is pioneering the use of fermentation and culturing to produce beneficial, effective products for use in the nutraceutical, functional food and cosmeceuticals industries. Toyo Shinyaku is Japan's largest developer of FOSHU (Food for Specialized Health Use) products and ODM (Original Design Manufacturer) of supplement and skin care products. Toyo Shinyaku follows rigorous standards of ISO 9001:2000 and ISO 22000:2005, and was one of the first Japanese companies to become Food and Drug Administration (FDA) Good Manufacturing Practices (GMP)-compliant for food products and dietary supplements.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a global direct selling company operating in 47 markets throughout Asia, the Americas and Europe. The company markets premium-quality personal care products under the Nu Skin(R) brand, science-based nutritional supplements under the Pharmanex(R) brand, and technology-based products and services under the Big Planet(R) brand. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskinenterprises.com.


'/>"/>
SOURCE Nu Skin Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Nu Skin Enterprises to Announce Second Quarter 2008 Results
2. Medline Receives Force Majeure Notice From Hong Ray Enterprises
3. Nu Skin Enterprises to Present at Oppenheimer Consumer Growth Conference
4. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant
5. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor
6. Nu Skin Enterprises Announces Slate of Candidates for its Board of Directors
7. Coventina Healthcare Enterprises, Inc. is Now ReGear Life Sciences, Inc.
8. Nu Skin Enterprises Declares Quarterly Dividend of $0.11
9. Nu Skin Enterprises Reports First-Quarter 2008 Results
10. FFF Enterprises Selects A10 Networks AX Series Advanced Traffic Manager
11. CJPS Enterprises Announces a Series of Seminars on Automotive Diversification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... ... made the 2017 Inc. 5000 with a three-year sales growth of 49 ... private companies and comprises the most comprehensive look at America’s independent entrepreneurs. This ...
(Date:8/23/2017)... Arizona (PRWEB) , ... August 23, 2017 , ... ... in the top 20% of hospitals nationally that earned the designation of High ... list. An overall rating of high performing indicates a hospital was significantly better than ...
(Date:8/23/2017)... ... 23, 2017 , ... MobilityWorks ®, the nation's largest ... 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. MobilityWorks (aka ... marking the twelfth year that the company has been included on the list. ...
(Date:8/23/2017)... ... 2017 , ... Virsys12, a Salesforce Gold Consulting Partner, continues ... of Kevin Keelan as a Senior Account Executive, based in the Denver, Colorado ... working with Virsys12 senior leadership to extend and develop the firm’s client portfolio ...
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017   Mostyn Law and Gulf Coast Regional ... Texas . The Mostyn Law family has had ... That is why Mostyn Law is partnering with Gulf ... show its appreciation. Blood supplies are running low. Gulf ... of hospital needs in August. That is why the blood center ...
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of the ... be in the beginning stages of an IPO. ... medications with the average cost of a prescription epilepsy drug being $450.00-$1200.00 ... AXIUM PHARMACEUTICALS, ... Another staggering figure is the fact that Americans ...
(Date:8/15/2017)...  AOTI Inc. announced today that its fully owned ... a New York City Office in Yonkers, New York ... Wound Oxygen (TWO 2 ) homecare therapy. This new East Coast ... Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment ... Advanced Oxygen Therapy ...
Breaking Medicine Technology: